{"recordsFiltered":48474,"recordsTotal":48474,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=39300","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=38700","results":[{"registry_id":"NCT07430410","publication_url":"https://clinicaltrials.gov/study/NCT07430410","title":"Human Factors and Clinical Validation of the CorDx Tyfast Flu A/B & COVID-19 At Home Multiplex Rapid Test Using Anterior Nares Nasal Samples for Over-The-Counter (OTC) Use","has_exemption":false,"start_date":"2026-02-12","completion_date":"2026-12-12","has_results":false,"results_due":false,"sponsor_name":"CorDx, Inc.","sponsor_slug":"cordx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04809714","publication_url":"https://clinicaltrials.gov/study/NCT04809714","title":"The Role of Blood Flow Restriction Therapy in the Postop Rehabilitation of Elderly Patients With Hip Fractures: A Randomized Controlled Pilot Study","has_exemption":false,"start_date":"2022-01-01","completion_date":"2026-12-13","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06118281","publication_url":"https://clinicaltrials.gov/study/NCT06118281","title":"ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction","has_exemption":false,"start_date":"2024-06-25","completion_date":"2026-12-14","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06430866","publication_url":"https://clinicaltrials.gov/study/NCT06430866","title":"A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Participants With Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy","has_exemption":false,"start_date":"2024-09-12","completion_date":"2026-12-14","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06348394","publication_url":"https://clinicaltrials.gov/study/NCT06348394","title":"Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-12-14","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06806137","publication_url":"https://clinicaltrials.gov/study/NCT06806137","title":"A Phase 3a, Observer-blind, Randomized, Controlled, Study to Evaluate the Immunogenicity and Safety of an Investigational Varicella Vaccine Compared With Varivax, When Given as a Second Dose to Healthy Children, 3 Months After the Administration of a First Dose at 12 to 15 Months of Age","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-12-14","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07013201","publication_url":"https://clinicaltrials.gov/study/NCT07013201","title":"A Proof-of-concept Phase 2a, Double-blind, 2-arm Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream 20 mg/g Compared With Cream Vehicle During a 16-week Treatment Period in Adult Subjects With Mild to Severe Palmoplantar Pustulosis","has_exemption":false,"start_date":"2025-09-11","completion_date":"2026-12-14","has_results":false,"results_due":false,"sponsor_name":"LEO Pharma","sponsor_slug":"leo-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938569","publication_url":"https://clinicaltrials.gov/study/NCT05938569","title":"Computer-Assisted Hair Restoration Study Using ARTAS System","has_exemption":false,"start_date":"2016-11-03","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Venus Concept","sponsor_slug":"venus-concept","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03817502","publication_url":"https://clinicaltrials.gov/study/NCT03817502","title":"A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia","has_exemption":false,"start_date":"2019-06-06","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Gedeon Richter Plc.","sponsor_slug":"gedeon-richter-plc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04502407","publication_url":"https://clinicaltrials.gov/study/NCT04502407","title":"IIT2019-20-Zumsteg-HPVOPC: Phase II Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer","has_exemption":false,"start_date":"2021-02-16","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05383196","publication_url":"https://clinicaltrials.gov/study/NCT05383196","title":"A Phase 1b/2 Study of Onvansertib in Combination With Paclitaxel in Triple-negative Metastatic Breast Cancer Patients","has_exemption":false,"start_date":"2022-09-30","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Antonio Giordano, MD","sponsor_slug":"antonio-giordano-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05507892","publication_url":"https://clinicaltrials.gov/study/NCT05507892","title":"Molecular Mechanisms of SGLT2 Inhibition in Diabetic Kidney Disease","has_exemption":false,"start_date":"2022-10-10","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669430","publication_url":"https://clinicaltrials.gov/study/NCT05669430","title":"An Open-Label Phase 1/2A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Advanced and/or Refractory Solid Tumor Malignancies","has_exemption":false,"start_date":"2023-03-23","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"GV20 Therapeutics","sponsor_slug":"gv20-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052163","publication_url":"https://clinicaltrials.gov/study/NCT06052163","title":"Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Tolerability of Bumetanide in Patients With Alzheimer's Disease.","has_exemption":false,"start_date":"2023-04-10","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05350774","publication_url":"https://clinicaltrials.gov/study/NCT05350774","title":"Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (IN-PASC)","has_exemption":false,"start_date":"2023-07-10","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","sponsor_slug":"national-institute-of-neurological-disorders-and-stroke-ninds","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444335","publication_url":"https://clinicaltrials.gov/study/NCT05444335","title":"Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years","has_exemption":false,"start_date":"2023-07-15","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05453396","publication_url":"https://clinicaltrials.gov/study/NCT05453396","title":"A Pilot Study of Loncastuximab Tesirine in Specific Populations of Relapsed/Refractory B-Cell Malignancies","has_exemption":false,"start_date":"2023-08-07","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05826743","publication_url":"https://clinicaltrials.gov/study/NCT05826743","title":"Safety and Effectiveness Evaluations of the COLO-BT™ (Colorectal Balloon Tube) as an Alternative Treatment to the Temporary Ileostomy Following Proctectomy","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"JSR Medical Co., Ltd.","sponsor_slug":"jsr-medical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06416085","publication_url":"https://clinicaltrials.gov/study/NCT06416085","title":"Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial","has_exemption":false,"start_date":"2024-06-06","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"University Health Network, Toronto","sponsor_slug":"university-health-network-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06607627","publication_url":"https://clinicaltrials.gov/study/NCT06607627","title":"An Open-Label, Single-arm Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, and Efficacy of Gefurulimab in Pediatric Patients (6 to < 18 Years of Age) With Generalized Myasthenia Gravis (gMG) Who Express Acetylcholine Receptor Antibodies (AChR+)","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06685848","publication_url":"https://clinicaltrials.gov/study/NCT06685848","title":"Multi-Center, Randomized, Controlled Cross-Over Study to Evaluate Safety and Effectiveness of Hypoxic RBCs Processed With the Hemanext ONE System vs Conventional RBCs in Patients With Transfusion-Dependent Haematological Malignancies","has_exemption":false,"start_date":"2024-11-29","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Hemanext","sponsor_slug":"hemanext","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06888128","publication_url":"https://clinicaltrials.gov/study/NCT06888128","title":"The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma","has_exemption":false,"start_date":"2025-01-30","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06708949","publication_url":"https://clinicaltrials.gov/study/NCT06708949","title":"A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)","has_exemption":false,"start_date":"2025-03-20","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850623","publication_url":"https://clinicaltrials.gov/study/NCT06850623","title":"A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer","has_exemption":false,"start_date":"2025-06-19","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"EXACT Therapeutics AS","sponsor_slug":"exact-therapeutics-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209410","publication_url":"https://clinicaltrials.gov/study/NCT07209410","title":"Impact of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,","sponsor_slug":"insight-eyecare-specialties-inc-dba-vision-source-eyecare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07435428","publication_url":"https://clinicaltrials.gov/study/NCT07435428","title":"A Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled and Open-label Study to Evaluate the Efficacy and Safety of a Single Dose of IPN10200 in the Improvement of Moderate to Severe Glabellar Lines in Adult Participants, and to Evaluate the Long-term Efficacy and Safety of Repeat Doses of IPN10200 in the Same Indication","has_exemption":false,"start_date":"2026-02-18","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827795","publication_url":"https://clinicaltrials.gov/study/NCT06827795","title":"An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)","has_exemption":false,"start_date":"2026-02-19","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Surgify Medical Oy","sponsor_slug":"surgify-medical-oy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07427797","publication_url":"https://clinicaltrials.gov/study/NCT07427797","title":"A Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of a Single Dose of IPN10200 in the Improvement of Moderate to Severe Glabellar Lines in Adult Participants","has_exemption":false,"start_date":"2026-02-27","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07452536","publication_url":"https://clinicaltrials.gov/study/NCT07452536","title":"A Pilot Clinical Study to Evidence Safety and Efficacy of Fracture Fixation of the Distal Radius Using a Bioresorbable Bone Adhesive to Augment Metal Hardware","has_exemption":false,"start_date":"2026-04-15","completion_date":"2026-12-15","has_results":false,"results_due":false,"sponsor_name":"RevBio","sponsor_slug":"revbio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02153229","publication_url":"https://clinicaltrials.gov/study/NCT02153229","title":"A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma","has_exemption":false,"start_date":"2014-06-02","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02581085","publication_url":"https://clinicaltrials.gov/study/NCT02581085","title":"Tocotrienol Against the Progression of End Stage Liver Disease","has_exemption":false,"start_date":"2019-11-01","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"Chandan Sen","sponsor_slug":"chandan-sen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03375307","publication_url":"https://clinicaltrials.gov/study/NCT03375307","title":"A Phase II Study of Olaparib (AZD2281) in Patients With Metastatic/Advanced Urothelial Carcinoma and Other Genitourinary Tumors With DNA-Repair Defects","has_exemption":false,"start_date":"2020-11-03","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04665037","publication_url":"https://clinicaltrials.gov/study/NCT04665037","title":"A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formulations in Pediatric Participants From Birth to Less Than 2 Years of Age With Possible, Probable, or Proven Invasive Fungal Infection","has_exemption":false,"start_date":"2022-02-22","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05503264","publication_url":"https://clinicaltrials.gov/study/NCT05503264","title":"A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Basket Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis","has_exemption":false,"start_date":"2022-09-27","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05756569","publication_url":"https://clinicaltrials.gov/study/NCT05756569","title":"Phase II Single-Arm Study of Enfortumab Vedotin (EV) Plus Pembrolizumab in the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology","has_exemption":false,"start_date":"2023-09-26","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254911","publication_url":"https://clinicaltrials.gov/study/NCT06254911","title":"Window of Opportunity Study of Pre-Operative Atezolizumab (ANTI PD-L1 ANTIBODY) for Patients With Resectable HPV Related Oropharyngeal Squamous Cell Carcinoma (OPSCC)","has_exemption":false,"start_date":"2023-10-27","completion_date":"2026-12-16","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06958536","publication_url":"https://clinicaltrials.gov/study/NCT06958536","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR442970 in Adults With Moderate to Severe Crohn's Disease","has_exemption":false,"start_date":"2025-06-03","completion_date":"2026-12-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06975722","publication_url":"https://clinicaltrials.gov/study/NCT06975722","title":"A Phase 2b, Multi-national, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Followed by a Long-term Extension to Evaluate the Efficacy and Safety of SAR442970 in Adult Participants With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2025-07-07","completion_date":"2026-12-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04573478","publication_url":"https://clinicaltrials.gov/study/NCT04573478","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function","has_exemption":false,"start_date":"2020-12-11","completion_date":"2026-12-18","has_results":false,"results_due":false,"sponsor_name":"Chinook Therapeutics, Inc.","sponsor_slug":"chinook-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06602479","publication_url":"https://clinicaltrials.gov/study/NCT06602479","title":"A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult Participants With Episodic Migraine","has_exemption":false,"start_date":"2024-10-07","completion_date":"2026-12-18","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06062810","publication_url":"https://clinicaltrials.gov/study/NCT06062810","title":"Explore the Relationship Between Single Nucleotide Polymorphisms and Raloxifene Response and Toxicity in Patients With Breast Cancer LCIS","has_exemption":false,"start_date":"2025-06-21","completion_date":"2026-12-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285044","publication_url":"https://clinicaltrials.gov/study/NCT07285044","title":"Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Pilot, Phase 2 Clinical Trial to Evaluate Administration of Cancer-Directed Therapy in the Patient's Homes Versus in Clinic in the Florida Panhandle and Surrounding Areas","has_exemption":false,"start_date":"2025-12-18","completion_date":"2026-12-18","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04194216","publication_url":"https://clinicaltrials.gov/study/NCT04194216","title":"Comparison of Outcomes in Rhinoplasty With the Use of Intraoperative Versus Postoperative Antibiotics","has_exemption":false,"start_date":"2020-05-20","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04644016","publication_url":"https://clinicaltrials.gov/study/NCT04644016","title":"Cord Blood Transplantation in Children and Young Adults With Hematologic Malignancies and Non-malignant Disorders","has_exemption":false,"start_date":"2020-11-20","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04775550","publication_url":"https://clinicaltrials.gov/study/NCT04775550","title":"B- PRISM (Precision Intervention Smoldering Myeloma): A Phase II Trial of Combination of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High- Risk Smoldering Multiple Myeloma","has_exemption":false,"start_date":"2021-03-08","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"Omar Nadeem, MD","sponsor_slug":"omar-nadeem-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04804293","publication_url":"https://clinicaltrials.gov/study/NCT04804293","title":"Treatment Monitoring of Carpal Tunnel Syndrome Using Shear Wave Elastography: A Pilot in Vivo Study","has_exemption":false,"start_date":"2021-03-15","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05170204","publication_url":"https://clinicaltrials.gov/study/NCT05170204","title":"A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-11-01","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06036420","publication_url":"https://clinicaltrials.gov/study/NCT06036420","title":"Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing","has_exemption":false,"start_date":"2023-10-20","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04529044","publication_url":"https://clinicaltrials.gov/study/NCT04529044","title":"A Phase II Pilot Study of (Lutetium (177Lu)-DOTATATE in Patients With Metastatic Breast Cancer","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486830","publication_url":"https://clinicaltrials.gov/study/NCT07486830","title":"A Double Blind, Placebo Controlled Study of IncobotulinumtoxinA in Patients With Provoked Vestibulodynia Associated With Overactive Pelvic Floor Muscle Dysfunction","has_exemption":false,"start_date":"2026-02-27","completion_date":"2026-12-20","has_results":false,"results_due":false,"sponsor_name":"Center for Vulvovaginal Disorders","sponsor_slug":"center-for-vulvovaginal-disorders","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05521789","publication_url":"https://clinicaltrials.gov/study/NCT05521789","title":"Erector Spinae Blocks for Thoracic Surgery","has_exemption":false,"start_date":"2022-07-22","completion_date":"2026-12-21","has_results":false,"results_due":false,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06921850","publication_url":"https://clinicaltrials.gov/study/NCT06921850","title":"A Multicenter, Open-Label Study to Assess The Pharmacokinetics And Safety of Bimekizumab in Pubertal Children And Adolescents With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-12-21","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03860857","publication_url":"https://clinicaltrials.gov/study/NCT03860857","title":"The BEACoN Study- Biomarker Exploration in Aging, Cognition and Neurodegeneration","has_exemption":false,"start_date":"2018-05-01","completion_date":"2026-12-22","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05675930","publication_url":"https://clinicaltrials.gov/study/NCT05675930","title":"A Multi-Center, Phase II, Randomized Double-Blind Trial to Evaluate the Efficacy and Safety of Photobiomodulation for the Treatment of Oral Chronic Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation (the LIGHT Trial)","has_exemption":false,"start_date":"2022-12-22","completion_date":"2026-12-22","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06185764","publication_url":"https://clinicaltrials.gov/study/NCT06185764","title":"A Phase 1/2, Randomized, Double-blind, Placebo-controlled Single- and Multiple-dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VX-670 in Adult Subjects With Myotonic Dystrophy Type 1","has_exemption":false,"start_date":"2024-02-20","completion_date":"2026-12-22","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06856577","publication_url":"https://clinicaltrials.gov/study/NCT06856577","title":"A Multi-Center, Randomized, Double-Masked, Active-Comparator-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration (ARTEMIS)","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-12-22","has_results":false,"results_due":false,"sponsor_name":"Adverum Biotechnologies, Inc.","sponsor_slug":"adverum-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07182240","publication_url":"https://clinicaltrials.gov/study/NCT07182240","title":"Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas","has_exemption":false,"start_date":"2025-12-22","completion_date":"2026-12-22","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05950165","publication_url":"https://clinicaltrials.gov/study/NCT05950165","title":"A Phase I/IIa, Open-label, Multicenter Study of the Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide to Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2020-01-15","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Cho Pharma Inc.","sponsor_slug":"cho-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05147558","publication_url":"https://clinicaltrials.gov/study/NCT05147558","title":"A Phase II Trial of Pembrolizumab Plus Lenvatinib for the Treatment of Patients With Advanced Uterine and Ovarian Carcinosarcomas","has_exemption":false,"start_date":"2021-12-23","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05668741","publication_url":"https://clinicaltrials.gov/study/NCT05668741","title":"A Phase 1/2 Dose Escalation Study Evaluating the Safety, and Tolerability and Efficacy of VX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator Therapy","has_exemption":false,"start_date":"2023-02-27","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06141486","publication_url":"https://clinicaltrials.gov/study/NCT06141486","title":"A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2023-12-27","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849298","publication_url":"https://clinicaltrials.gov/study/NCT05849298","title":"An International Prospective Open-label, Multi-center, Randomized, Non-comparative Phase II Study of Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) Alone and Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) in Combination With Androgen Receptor Pathway Inhibitors in Patients With PSMA PET Scan Positive Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2024-01-03","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06402331","publication_url":"https://clinicaltrials.gov/study/NCT06402331","title":"A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of FPI-2265 (225Ac-PSMA-I&T) in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2024-03-05","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Fusion Pharmaceuticals Inc.","sponsor_slug":"fusion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06500702","publication_url":"https://clinicaltrials.gov/study/NCT06500702","title":"A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, and Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)","has_exemption":false,"start_date":"2024-12-19","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07340320","publication_url":"https://clinicaltrials.gov/study/NCT07340320","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2026-02-05","completion_date":"2026-12-23","has_results":false,"results_due":false,"sponsor_name":"Corxel Pharmaceuticals","sponsor_slug":"corxel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04820036","publication_url":"https://clinicaltrials.gov/study/NCT04820036","title":"A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG): Effects of ESG on Non-Alcoholic Steatohepatitis (NASH) and Portal Pressure Gradient in Patients With Obesity and NASH With Advanced Fibrosis","has_exemption":false,"start_date":"2021-05-06","completion_date":"2026-12-24","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05060991","publication_url":"https://clinicaltrials.gov/study/NCT05060991","title":"Impact of Immunosuppression Adjustment on the Immune Response to SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients (ADIVKT)","has_exemption":false,"start_date":"2021-09-24","completion_date":"2026-12-24","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07521475","publication_url":"https://clinicaltrials.gov/study/NCT07521475","title":"EVOLVE: Evaluation of the Fully Closed Loop Omnipod® System for Safety and Efficacy in Adults With Type 2 Diabetes","has_exemption":false,"start_date":"2026-04-20","completion_date":"2026-12-24","has_results":false,"results_due":false,"sponsor_name":"Insulet Corporation","sponsor_slug":"insulet-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03811561","publication_url":"https://clinicaltrials.gov/study/NCT03811561","title":"Long-term Effects of Semaglutide on Diabetic Retinopathy in Subjects With Type 2 Diabetes","has_exemption":false,"start_date":"2019-05-08","completion_date":"2026-12-25","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05578326","publication_url":"https://clinicaltrials.gov/study/NCT05578326","title":"Study of Trilaciclib and Lurbinectedin in Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-10-12","completion_date":"2026-12-25","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06740630","publication_url":"https://clinicaltrials.gov/study/NCT06740630","title":"A Phase 3a, Observer-blind, Randomized, Controlled Study to Demonstrate Lot-to-lot Consistency and Evaluate the Immunogenicity and Safety of an Investigational Varicella Vaccine Compared With Varivax, Administered as a First Dose to Healthy Children 12 to 15 Months of Age","has_exemption":false,"start_date":"2025-01-10","completion_date":"2026-12-25","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219615","publication_url":"https://clinicaltrials.gov/study/NCT07219615","title":"A PHASE 2B RANDOMIZED, DOUBLE-BLIND, 12-WEEK PLACEBO-CONTROLLED STUDY WITH A 12-WEEK DOUBLE-BLIND EXTENSION PERIOD TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF RITLECITINIB (PF-06651600) IN ADULT PARTICIPANTS WITH CHRONIC SPONTANEOUS URTICARIA","has_exemption":false,"start_date":"2025-10-30","completion_date":"2026-12-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04498117","publication_url":"https://clinicaltrials.gov/study/NCT04498117","title":"A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma","has_exemption":false,"start_date":"2020-08-25","completion_date":"2026-12-26","has_results":false,"results_due":false,"sponsor_name":"CanariaBio Inc.","sponsor_slug":"canariabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06212999","publication_url":"https://clinicaltrials.gov/study/NCT06212999","title":"A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2024-01-30","completion_date":"2026-12-26","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05563220","publication_url":"https://clinicaltrials.gov/study/NCT05563220","title":"A Phase 1b/2, Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer","has_exemption":false,"start_date":"2023-01-24","completion_date":"2026-12-27","has_results":false,"results_due":false,"sponsor_name":"Stemline Therapeutics, Inc.","sponsor_slug":"stemline-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03729804","publication_url":"https://clinicaltrials.gov/study/NCT03729804","title":"A Randomized, Open-label Phase 3 Study of Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)","has_exemption":false,"start_date":"2019-05-07","completion_date":"2026-12-28","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05144997","publication_url":"https://clinicaltrials.gov/study/NCT05144997","title":"LORLATINIB (PF-06463922) CONTINUATION PROTOCOL: AN OPEN-LABEL, SINGLE-ARM CONTINUATION STUDY FOR PARTICIPANTS WITH ALK-POSITIVE OR ROS1-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) CONTINUING FROM PFIZER SPONSORED LORLATINIB CLINICAL STUDIES","has_exemption":false,"start_date":"2021-12-28","completion_date":"2026-12-28","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05555862","publication_url":"https://clinicaltrials.gov/study/NCT05555862","title":"A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Suppositories for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)","has_exemption":false,"start_date":"2023-02-10","completion_date":"2026-12-28","has_results":false,"results_due":false,"sponsor_name":"Frantz Viral Therapeutics, LLC","sponsor_slug":"frantz-viral-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05588388","publication_url":"https://clinicaltrials.gov/study/NCT05588388","title":"IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases","has_exemption":false,"start_date":"2024-08-11","completion_date":"2026-12-28","has_results":false,"results_due":false,"sponsor_name":"Kamya Sankar","sponsor_slug":"kamya-sankar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226076","publication_url":"https://clinicaltrials.gov/study/NCT07226076","title":"Reduction of Post-op Pain and Opioid Consumption With the Addition of Methadone in Total Knee Arthroplasty: a Double-blind Randomized Control Trial","has_exemption":false,"start_date":"2026-01-08","completion_date":"2026-12-28","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02923778","publication_url":"https://clinicaltrials.gov/study/NCT02923778","title":"A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma","has_exemption":false,"start_date":"2019-12-31","completion_date":"2026-12-29","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05036096","publication_url":"https://clinicaltrials.gov/study/NCT05036096","title":"Cone Beam Breast CT for Breast Cancer Screening","has_exemption":false,"start_date":"2021-10-30","completion_date":"2026-12-29","has_results":false,"results_due":false,"sponsor_name":"Koning Corporation","sponsor_slug":"koning-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290687","publication_url":"https://clinicaltrials.gov/study/NCT06290687","title":"Phase II Trial on the Safety and Efficacy of Partial Cystectomy and Extended Pelvic Lymph Node Dissection With Standard of Care Perioperative Systemic Therapy in the Management of Muscle-Invasive Bladder Cancer (PRESERVE Trial)","has_exemption":false,"start_date":"2025-02-18","completion_date":"2026-12-29","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06618157","publication_url":"https://clinicaltrials.gov/study/NCT06618157","title":"Connectomic Guided Deep Brain Stimulation (DBS) for Parkinson's Disease","has_exemption":false,"start_date":"2026-02-16","completion_date":"2026-12-29","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298356","publication_url":"https://clinicaltrials.gov/study/NCT07298356","title":"Automated Applanation Tonometry - Updated","has_exemption":false,"start_date":"2026-03-02","completion_date":"2026-12-29","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07511361","publication_url":"https://clinicaltrials.gov/study/NCT07511361","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital","has_exemption":false,"start_date":"2026-04-20","completion_date":"2026-12-29","has_results":false,"results_due":false,"sponsor_name":"Kardigan, Inc.","sponsor_slug":"kardigan-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03259867","publication_url":"https://clinicaltrials.gov/study/NCT03259867","title":"Phase IIA Single-Arm Study of Treatment of Patients With Advanced Liver Cancer With a Combination of TATE (Transarterial Tirapazamine Embolization) Followed by an Anti-PD-1 Monoclonal Antibody","has_exemption":false,"start_date":"2017-07-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Teclison Ltd.","sponsor_slug":"teclison-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03250975","publication_url":"https://clinicaltrials.gov/study/NCT03250975","title":"Incidence of Acute Laryngeal Injury Following Endotracheal Intubation","has_exemption":false,"start_date":"2017-08-19","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03596086","publication_url":"https://clinicaltrials.gov/study/NCT03596086","title":"Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy Combination With Radiotherapy and Chemotherapy for Recurrent Glioblastoma Multiforme","has_exemption":false,"start_date":"2017-12-11","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"David Baskin MD","sponsor_slug":"david-baskin-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03458429","publication_url":"https://clinicaltrials.gov/study/NCT03458429","title":"Safety and Efficacy of GMFFP From Young Healthy Donors (18-35), Treated With G-CSF to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals","has_exemption":false,"start_date":"2018-02-05","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Dipnarine Maharaj","sponsor_slug":"dipnarine-maharaj","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03383419","publication_url":"https://clinicaltrials.gov/study/NCT03383419","title":"Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients","has_exemption":false,"start_date":"2018-03-20","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03592472","publication_url":"https://clinicaltrials.gov/study/NCT03592472","title":"A Randomized, Phase 3, Double-blind, Placebo-controlled Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma(RENAVIV)","has_exemption":false,"start_date":"2018-07-17","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Xynomic Pharmaceuticals, Inc.","sponsor_slug":"xynomic-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03776487","publication_url":"https://clinicaltrials.gov/study/NCT03776487","title":"Pilot Study of Dual Checkpoint Inhibition Followed by Immuno-Chemoradiation in Patients With Resectable Gastric Adenocarcinoma (Concept ID 2016-NIV-0551)","has_exemption":false,"start_date":"2019-01-07","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03822312","publication_url":"https://clinicaltrials.gov/study/NCT03822312","title":"A Pilot Study of Digital Breast Tomosynthesis Guided Near-infrared Tomographic Optical Breast Imaging (DBT-TOBI) in Monitoring Response of Breast Cancer to Neoadjuvant Therapy","has_exemption":false,"start_date":"2019-02-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03809286","publication_url":"https://clinicaltrials.gov/study/NCT03809286","title":"The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder","has_exemption":false,"start_date":"2019-06-24","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03998657","publication_url":"https://clinicaltrials.gov/study/NCT03998657","title":"A Continued Access Study to Evaluate Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04278131","publication_url":"https://clinicaltrials.gov/study/NCT04278131","title":"Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP in Patients With Retinitis Pigmentosa","has_exemption":false,"start_date":"2020-02-06","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Bionic Sight LLC","sponsor_slug":"bionic-sight-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04722692","publication_url":"https://clinicaltrials.gov/study/NCT04722692","title":"Sentinel Lymph Node Biopsy in Ductal Cancer in Situ or Unclear Lesions of the Breast and How to Not do it. An Open-label, Phase 3, Randomised Controlled Trial. (SentiNot 2.0).","has_exemption":false,"start_date":"2020-03-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Uppsala University","sponsor_slug":"uppsala-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04434040","publication_url":"https://clinicaltrials.gov/study/NCT04434040","title":"A Single Arm Phase 2 Trial of Atezolizumab With Sacituzumab Govitecan to Prevent Recurrence in Triple Negative Breast Cancer (ASPRIA)","has_exemption":false,"start_date":"2020-07-02","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04807530","publication_url":"https://clinicaltrials.gov/study/NCT04807530","title":"Causal Role of Medial Prefrontal Neural Activity in Self-Agency in Schizophrenia","has_exemption":false,"start_date":"2020-11-12","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04658862","publication_url":"https://clinicaltrials.gov/study/NCT04658862","title":"A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder Who Are Not Receiving Radical Cystectomy","has_exemption":false,"start_date":"2020-12-07","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04576117","publication_url":"https://clinicaltrials.gov/study/NCT04576117","title":"A Phase 3 Study of Selumetinib (NSC# 748727) or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations","has_exemption":false,"start_date":"2021-02-16","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04585477","publication_url":"https://clinicaltrials.gov/study/NCT04585477","title":"Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)","has_exemption":false,"start_date":"2021-04-08","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03606967","publication_url":"https://clinicaltrials.gov/study/NCT03606967","title":"Randomized Phase 2 Clinical Trial of Nab-Paclitaxel + Durvalumab (MEDI4736) + Tremelimumab + Neoantigen Vaccine Vs. Nab-Paclitaxel + Durvalumab (MEDI4736) + Tremelimumab in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2021-04-13","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04588922","publication_url":"https://clinicaltrials.gov/study/NCT04588922","title":"A Phase I/IIa, Open-Label Dose Escalation and Dose Expansion Study of Intravenous GFH009 Single Agent and in Combination With Venetoclax and Azacitidine in Patients With Relapsed/Refractory Hematologic Malignancies and High-Risk Newly Diagnosed AML","has_exemption":false,"start_date":"2021-05-10","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Sellas Life Sciences Group","sponsor_slug":"sellas-life-sciences-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04903535","publication_url":"https://clinicaltrials.gov/study/NCT04903535","title":"Does a Flashlight Used to Detect Pet Biological Fluids on Human Skin and Other Surfaces Increase Gas Phase Nitric Oxide Levels?","has_exemption":false,"start_date":"2021-05-10","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04368806","publication_url":"https://clinicaltrials.gov/study/NCT04368806","title":"A 48-Weeks, Phase 2b/3a, Double-Blind, Randomized, Placebo Controlled, Multi-center, Superiority Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells in Patients Diagnosed as Knee Osteoarthritis","has_exemption":false,"start_date":"2021-05-26","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Nature Cell Co. Ltd.","sponsor_slug":"nature-cell-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04849728","publication_url":"https://clinicaltrials.gov/study/NCT04849728","title":"A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3","has_exemption":false,"start_date":"2021-08-19","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Inventiva Pharma","sponsor_slug":"inventiva-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04920318","publication_url":"https://clinicaltrials.gov/study/NCT04920318","title":"Enhancing Language Function in Primary Progressive Aphasia (PPA) With Transcranial Direct Current Stimulation (tDCS)","has_exemption":false,"start_date":"2021-08-30","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05964907","publication_url":"https://clinicaltrials.gov/study/NCT05964907","title":"Optimizing Phototesting and Investigating Photobiology of Visible Light","has_exemption":false,"start_date":"2021-10-06","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05060016","publication_url":"https://clinicaltrials.gov/study/NCT05060016","title":"A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Tarlatamab in Subjects With Relapsed/Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-301).","has_exemption":false,"start_date":"2021-12-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05281237","publication_url":"https://clinicaltrials.gov/study/NCT05281237","title":"Feasibility and Efficacy of the AveCure Flexible Microwave Ablation Probe for Peripheral Lung Nodule","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05478551","publication_url":"https://clinicaltrials.gov/study/NCT05478551","title":"Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05023018","publication_url":"https://clinicaltrials.gov/study/NCT05023018","title":"An Open-Label, Phase 2 Study of NEO100 in Participants With Residual, Progressive or Recurrent High-Grade Meningioma","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Neonc Technologies, Inc.","sponsor_slug":"neonc-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05465538","publication_url":"https://clinicaltrials.gov/study/NCT05465538","title":"Effect of Cannabis Use on Synaptic Density in Older Adults","has_exemption":false,"start_date":"2022-07-06","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05335993","publication_url":"https://clinicaltrials.gov/study/NCT05335993","title":"Phase 2, Single Arm Clinical Trial to Evaluate the Safety and Activity of Oregovomab and Niraparib as a Combinatorial Immune Priming Strategy in Subjects With Platinum Sensitive Recurrent Ovarian Cancer","has_exemption":false,"start_date":"2022-07-25","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"CanariaBio Inc.","sponsor_slug":"canariabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05501262","publication_url":"https://clinicaltrials.gov/study/NCT05501262","title":"Comparative Effectiveness of Cryoablation Using the ICE-Seed Cryoablation Needle With Steroid and Lidocaine Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma","has_exemption":false,"start_date":"2022-07-25","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05508165","publication_url":"https://clinicaltrials.gov/study/NCT05508165","title":"IRB: #12530 Prospective, Randomized Study to Assess Clinical Outcomes and Patient Satisfaction of Virtual vs. In-Person Workup and Treatment of Lower Urinary Tract Symptoms","has_exemption":false,"start_date":"2022-08-30","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05283226","publication_url":"https://clinicaltrials.gov/study/NCT05283226","title":"A Phase 2 Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy","has_exemption":false,"start_date":"2022-09-30","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"NATCO Pharma Ltd.","sponsor_slug":"natco-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05221021","publication_url":"https://clinicaltrials.gov/study/NCT05221021","title":"Vaginal Estradiol vs Oral Beta-3 Agonist for Treatment of Overactive Bladder Syndrome: A Single-Therapy, Double-Blind, Randomized Controlled Trial","has_exemption":false,"start_date":"2022-10-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Walter Reed National Military Medical Center","sponsor_slug":"walter-reed-national-military-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05509933","publication_url":"https://clinicaltrials.gov/study/NCT05509933","title":"Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2022-11-09","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04589819","publication_url":"https://clinicaltrials.gov/study/NCT04589819","title":"Fracture Recovery for Returning to Duty (Teriparatide STRONG)","has_exemption":false,"start_date":"2022-12-08","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of South Carolina","sponsor_slug":"university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05683808","publication_url":"https://clinicaltrials.gov/study/NCT05683808","title":"Venous Thromboembolism Prevention in Outpatients With Glioma","has_exemption":false,"start_date":"2023-01-16","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Vermont Medical Center","sponsor_slug":"university-of-vermont-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05769348","publication_url":"https://clinicaltrials.gov/study/NCT05769348","title":"Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)","has_exemption":false,"start_date":"2023-01-26","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05739981","publication_url":"https://clinicaltrials.gov/study/NCT05739981","title":"Phase II Study Evaluating the Effect of IMNN-001 on Second Look Laparoscopy (SLL) in Combination With Bevacizumab (BEV) and Neoadjuvant Chemotherapy (NACT) in Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer","has_exemption":false,"start_date":"2023-02-10","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Imunon","sponsor_slug":"imunon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05573555","publication_url":"https://clinicaltrials.gov/study/NCT05573555","title":"TACTIVE-U: AN INTERVENTIONAL SAFETY AND EFFICACY PHASE 1B/2, OPEN-LABEL UMBRELLA STUDY TO INVESTIGATE TOLERABILITY, PK, AND ANTITUMOR ACTIVITY OF VEPDEGESTRANT (ARV-471/PF-07850327), AN ORAL PROTEOLYSIS TARGETING CHIMERA, IN COMBINATION WITH OTHER ANTICANCER TREATMENTS IN PARTICIPANTS AGED 18 YEARS AND OVER WITH ER+ ADVANCED OR METASTATIC BREAST CANCER, SUB-STUDY B (ARV-471 IN COMBINATION WITH RIBOCICLIB)","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05797519","publication_url":"https://clinicaltrials.gov/study/NCT05797519","title":"Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"VDyne, Inc.","sponsor_slug":"vdyne-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05351294","publication_url":"https://clinicaltrials.gov/study/NCT05351294","title":"Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Management of Metastatic Malignancies","has_exemption":false,"start_date":"2023-07-13","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05639933","publication_url":"https://clinicaltrials.gov/study/NCT05639933","title":"A Randomized, Placebo-controlled, Parallel Phase 2a Dose-ranging Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors","has_exemption":false,"start_date":"2023-07-19","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Hoth Therapeutics, Inc.","sponsor_slug":"hoth-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05909397","publication_url":"https://clinicaltrials.gov/study/NCT05909397","title":"A PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF VEPDEGESTRANT (ARV-471/PF-07850327) PLUS PALBOCICLIB VERSUS LETROZOLE PLUS PALBOCICLIB FOR THE TREATMENT OF PARTICIPANTS WITH ESTROGEN RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER WHO HAVE NOT RECEIVED ANY PRIOR SYSTEMIC ANTI CANCER TREATMENT FOR ADVANCED DISEASE (VERITAC-3)","has_exemption":false,"start_date":"2023-08-09","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411418","publication_url":"https://clinicaltrials.gov/study/NCT06411418","title":"Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Jacobs institute","sponsor_slug":"jacobs-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766943","publication_url":"https://clinicaltrials.gov/study/NCT05766943","title":"The Efficacy of the Smart Pass Filter to Reduce the Risk for Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks From Myopotential Interference","has_exemption":false,"start_date":"2023-11-06","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05603026","publication_url":"https://clinicaltrials.gov/study/NCT05603026","title":"Comparison of Hemodynamic Performance of Transcatheter Aortic Valve Replacement With Supra-Annular Self-Expanding Versus Balloon-Expandable Valves Assessed by Exercise Cardiovascular Magnetic Resonance","has_exemption":false,"start_date":"2023-11-21","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06189781","publication_url":"https://clinicaltrials.gov/study/NCT06189781","title":"Peri-operative Use of a Pain Injection Versus Epidural in Pediatric Patients With Cerebral Palsy","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06164613","publication_url":"https://clinicaltrials.gov/study/NCT06164613","title":"Use of Cinnamomum Verum Extract Versus Placebo for Induction of Labor and Reduction of Physiological Phase 2-3 of Labor. Double-blind Randomized Clinical Trial. CINNALAB TRIAL","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Universidad Nacional Autonoma de Honduras","sponsor_slug":"universidad-nacional-autonoma-de-honduras","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159634","publication_url":"https://clinicaltrials.gov/study/NCT06159634","title":"Comparison of the Efficacy of Using a Traction Device in Colonic Endoscopic Submucosal Dissection Versus Conventional ESD: A Randomized Clinical Trial","has_exemption":false,"start_date":"2023-12-05","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996133","publication_url":"https://clinicaltrials.gov/study/NCT05996133","title":"Comparing Multifidus Cervicis Plane Block Vs. Sham Block, In Reducing Postoperative Pain And Opioid Consumption In Patients Undergoing Elective Primary Posterior Cervical Spine Fusion Surgery","has_exemption":false,"start_date":"2023-12-12","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Hartford Hospital","sponsor_slug":"hartford-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05786443","publication_url":"https://clinicaltrials.gov/study/NCT05786443","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Empagliflozin Among Patients Initiating Hemodialysis for the Treatment of End-Stage Kidney Disease","has_exemption":false,"start_date":"2024-01-31","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06221501","publication_url":"https://clinicaltrials.gov/study/NCT06221501","title":"Safety and Efficacy of Perioperative Efgartigimod Combined With Thymectomy for Thymoma and Myasthenia Gravis: A Prospective, Single-arm Study","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Shanghai Zhongshan Hospital","sponsor_slug":"shanghai-zhongshan-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05344417","publication_url":"https://clinicaltrials.gov/study/NCT05344417","title":"Impact of Low Pressure Pneumoperitoneum on Postoperative Ileus and Gastrointestinal Dysfunction in Patients Undergoing Laparoscopic Large Bowel Surgery","has_exemption":false,"start_date":"2024-03-06","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05231122","publication_url":"https://clinicaltrials.gov/study/NCT05231122","title":"Randomized Phase 2 Clinical Trial of Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 in Patients With Recurrent Ovarian Cancer","has_exemption":false,"start_date":"2024-03-12","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06308120","publication_url":"https://clinicaltrials.gov/study/NCT06308120","title":"A Randomized Controlled Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB","has_exemption":false,"start_date":"2024-03-20","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06381791","publication_url":"https://clinicaltrials.gov/study/NCT06381791","title":"Cannabidiol (CBD) As A Pain Adjunct in Orthopedic Surgical Patients: A Randomized Control Trial","has_exemption":false,"start_date":"2024-05-24","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06559306","publication_url":"https://clinicaltrials.gov/study/NCT06559306","title":"A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-(Milligram) mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms","has_exemption":false,"start_date":"2024-07-25","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06388941","publication_url":"https://clinicaltrials.gov/study/NCT06388941","title":"A Randomized, Controlled Study to Evaluate LNP023 (Iptacopan) in Patients With Active ANCA-associated Vasculitis","has_exemption":false,"start_date":"2024-08-05","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145633","publication_url":"https://clinicaltrials.gov/study/NCT06145633","title":"Vorinostat to Augment Response to 177Lutetium-PSMA-617 in the Treatment of Patients With PSMA-Low Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2024-09-18","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284486","publication_url":"https://clinicaltrials.gov/study/NCT06284486","title":"A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib","has_exemption":false,"start_date":"2024-09-23","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06830109","publication_url":"https://clinicaltrials.gov/study/NCT06830109","title":"Nasal Obstruction Randomized Trial With Oxymetazoline and Corticosteroids","has_exemption":false,"start_date":"2024-10-15","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06677190","publication_url":"https://clinicaltrials.gov/study/NCT06677190","title":"A Phase II Trial of Belzutifan in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary or Clear Cell Carcinoma of Other Gynecologic Origin","has_exemption":false,"start_date":"2024-12-20","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04790240","publication_url":"https://clinicaltrials.gov/study/NCT04790240","title":"The Trial Uses Medicinal Herbs to Direct T Cells to Engulf the COVID-19 Virus and Protect the Organs Well","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"All Natural Medicine Clinic, LLC","sponsor_slug":"all-natural-medicine-clinic-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028477","publication_url":"https://clinicaltrials.gov/study/NCT06028477","title":"Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study","has_exemption":false,"start_date":"2025-01-10","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06514794","publication_url":"https://clinicaltrials.gov/study/NCT06514794","title":"A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in Patients With Relapsed/Refractory Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-RRex)","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Wugen, Inc.","sponsor_slug":"wugen-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06794996","publication_url":"https://clinicaltrials.gov/study/NCT06794996","title":"A Phase 2b, Open-label Study to Evaluate the Efficacy and Safety of Inaxaplin in Subjects With Proteinuric APOL1-mediated Kidney Disease With or Without Comorbidities That May Independently Contribute to Chronic Kidney Disease","has_exemption":false,"start_date":"2025-02-04","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223242","publication_url":"https://clinicaltrials.gov/study/NCT07223242","title":"Tailored Exercise Training Study Among Adults With HFpEF","has_exemption":false,"start_date":"2025-02-18","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518057","publication_url":"https://clinicaltrials.gov/study/NCT06518057","title":"A Multi-Center Phase 2 Study of Hippocampal Avoidance in Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors","has_exemption":false,"start_date":"2025-03-03","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06862284","publication_url":"https://clinicaltrials.gov/study/NCT06862284","title":"Efficacy, Safety and Immunological Effect of Upadacitinib in the Treatment of Primary Sjögren's Syndrome","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Peking University People's Hospital","sponsor_slug":"peking-university-peoples-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06826326","publication_url":"https://clinicaltrials.gov/study/NCT06826326","title":"A 'Proof of Concept' Study to Identify Neural Target Engagement of Escitalopram in Adolescents With Autism Spectrum Disorder","has_exemption":false,"start_date":"2025-04-28","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Kathryn Unruh","sponsor_slug":"kathryn-unruh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06782373","publication_url":"https://clinicaltrials.gov/study/NCT06782373","title":"PAXIS: A Randomized, Double-blind, Placebo-controlled Dose-finding Phase 2 Study (Part 1) Followed by an Open-label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients With VEXAS Syndrome","has_exemption":false,"start_date":"2025-05-28","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516055","publication_url":"https://clinicaltrials.gov/study/NCT06516055","title":"A Phase IIa Non-Blinded Study of Safety, Tolerability and Efficacy of S1B-408 in Women With Orgasmic Dysfunction","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"S1 Biopharma, Inc.","sponsor_slug":"s1-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216157","publication_url":"https://clinicaltrials.gov/study/NCT07216157","title":"The NoSeal Trial - Nasal Outcome Study Evaluating Artificial Leak-Sealing: A Prospective, Randomized, Controlled, Single-Blinded, Single-Center Clinical Trial Comparing Fibrin Glue (Tisseel®) and a Two-Component Synthetic Polymer Sealant (PEI/PEG, Adherus®) Versus No Sealant for the Prevention of Cerebrospinal Fluid Leak and Promotion of Wound Healing Following Endonasal Skull Base Surgery, Designed in Accordance With the SPIRIT 2025 Guidelines","has_exemption":false,"start_date":"2025-08-15","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Maria Sklodowska-Curie National Research Institute of Oncology","sponsor_slug":"maria-sklodowska-curie-national-research-institute-of-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07118449","publication_url":"https://clinicaltrials.gov/study/NCT07118449","title":"A 26-Week (With 26 Week Extension) Randomized, Multi-Center, Double-Blind Phase 2 Study to Evaluate the Efficacy and Safety of XC001 Gene Therapy as an Adjunct to Coronary Artery Bypass Graft Surgery for Patients With Symptomatic Coronary Artery Disease With Left Ventricular Dysfunction at Risk for Incomplete Revascularization","has_exemption":false,"start_date":"2025-08-27","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"XyloCor Therapeutics, Inc.","sponsor_slug":"xylocor-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06599697","publication_url":"https://clinicaltrials.gov/study/NCT06599697","title":"The MIGHT Trial - An Exploratory Clinical Trial of Intravenous Immunoglobulin (IVIG) in Anti-3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) Immune Mediated Necrotizing Myopathy (IMNM)","has_exemption":false,"start_date":"2025-10-27","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174297","publication_url":"https://clinicaltrials.gov/study/NCT07174297","title":"To Compare the Efficacy and Safety of Acotiamide Versus Itopride in Patient With Post Prandial Distress Syndrome Type of Functional Dyspepsia","has_exemption":false,"start_date":"2025-10-30","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Getz Pharma","sponsor_slug":"getz-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217444","publication_url":"https://clinicaltrials.gov/study/NCT07217444","title":"Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2025-11-13","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301411","publication_url":"https://clinicaltrials.gov/study/NCT07301411","title":"An Exploratory Clinical Trial Evaluating Navigational Bronchoscopy System and Bronchoscope and Accessories in Combination With Cryoablation Therapy Device for the Treatment of Lung Malignancies","has_exemption":false,"start_date":"2025-11-21","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Tianjin Puli Ark Medical Technology Co., Ltd.","sponsor_slug":"tianjin-puli-ark-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06876259","publication_url":"https://clinicaltrials.gov/study/NCT06876259","title":"Intelligent Medical Assessment for Guiding Ear Infection Treatment","has_exemption":false,"start_date":"2025-12-04","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Timothy Shope","sponsor_slug":"timothy-shope","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214571","publication_url":"https://clinicaltrials.gov/study/NCT07214571","title":"A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability, and Efficacy of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus Who Are at High Risk of Progression to Severe Disease","has_exemption":false,"start_date":"2025-12-11","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07355257","publication_url":"https://clinicaltrials.gov/study/NCT07355257","title":"Safety and Efficacy of Telitacicept in Inflammatory Myopathies","has_exemption":false,"start_date":"2026-02-02","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Zhongming Qiu","sponsor_slug":"zhongming-qiu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06914596","publication_url":"https://clinicaltrials.gov/study/NCT06914596","title":"Randomized Controlled Clinical Trial To Assess The Safety and Effectiveness of A Periodontal Hydrogel Dressing (Emanate Perio PODS) On Wound Healing Post-Scaling and Root Planing","has_exemption":false,"start_date":"2026-02-19","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"McGuire Institute","sponsor_slug":"mcguire-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07428564","publication_url":"https://clinicaltrials.gov/study/NCT07428564","title":"Workflow Study of the VARIPULSE™ Catheter With the TRUPULSE™ Generator for Treatment of Persistent Atrial Fibrillation (PsAF) With the New VARIPULSE™ Pro Software","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06876896","publication_url":"https://clinicaltrials.gov/study/NCT06876896","title":"Comparative Study of Intra-abdominal Pressure Using Accuryn Monitoring System During Pulsed Field Ablation (PFA) for Treatment of Atrial Fibrillation and/or Atrial Flutter Under Sedation.","has_exemption":false,"start_date":"2026-03-03","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07429214","publication_url":"https://clinicaltrials.gov/study/NCT07429214","title":"Workflow Study of the VARIPULSE™ Catheter With the TRUPULSE™ Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF) or Persistent Atrial Fibrillation (PsAF) With the New VARIPULSE™ Pro Software","has_exemption":false,"start_date":"2026-03-23","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095972","publication_url":"https://clinicaltrials.gov/study/NCT07095972","title":"Optimizing Glycemic Control in Metabolic Surgery With Continuous Glucose Monitoring","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Pennington Biomedical Research Center","sponsor_slug":"pennington-biomedical-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226245","publication_url":"https://clinicaltrials.gov/study/NCT07226245","title":"Evaluating Pharmacokinetics of Three Methadone Dosing Strategies During Cardiac Surgery With Cardiopulmonary Bypass","has_exemption":false,"start_date":"2026-05-31","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161843","publication_url":"https://clinicaltrials.gov/study/NCT07161843","title":"Determine the Efficacy of Investigational Drug QRX-3 in Hospitalized Patients With Acute Tubular Necrosis Pattern of Acute Renal Failure","has_exemption":false,"start_date":"2026-06-30","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Ebima Clifford Okundaye","sponsor_slug":"ebima-clifford-okundaye","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06566339","publication_url":"https://clinicaltrials.gov/study/NCT06566339","title":"Robotically Assisted Anterior Eye Examinations for Acute Eye Care","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-12-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00920972","publication_url":"https://clinicaltrials.gov/study/NCT00920972","title":"A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime","has_exemption":false,"start_date":"2001-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01653080","publication_url":"https://clinicaltrials.gov/study/NCT01653080","title":"Dynamic Contrast Enhanced Magnetic Resonance Imaging for Non-Invasive Diagnostic Work-Up in Solid Tumors of the Eye and Orbit.","has_exemption":false,"start_date":"2006-05-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00392353","publication_url":"https://clinicaltrials.gov/study/NCT00392353","title":"A Phase 1/2 Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination With Azacitidine in Patients With the Myelodysplastic Syndrome (MDS)","has_exemption":false,"start_date":"2006-11-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00466531","publication_url":"https://clinicaltrials.gov/study/NCT00466531","title":"A Phase I/IIa Trial For The Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19","has_exemption":false,"start_date":"2007-03-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00494182","publication_url":"https://clinicaltrials.gov/study/NCT00494182","title":"A Phase II Study of Sorafenib in Combination With Carboplatin and Paclitaxel in Metastatic or Recurrent Head and Neck Squamous Cell Cancer","has_exemption":false,"start_date":"2007-04-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00540761","publication_url":"https://clinicaltrials.gov/study/NCT00540761","title":"Natural History of Vulnerable Coronary Plaques","has_exemption":false,"start_date":"2007-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01653093","publication_url":"https://clinicaltrials.gov/study/NCT01653093","title":"Imaging of the Prostate Gland Using High Field Strength 3T MRI","has_exemption":false,"start_date":"2007-09-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00335816","publication_url":"https://clinicaltrials.gov/study/NCT00335816","title":"Timing of Rectal Cancer Response to Chemoradiation","has_exemption":false,"start_date":"2008-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00877500","publication_url":"https://clinicaltrials.gov/study/NCT00877500","title":"A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer","has_exemption":false,"start_date":"2009-03-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00900497","publication_url":"https://clinicaltrials.gov/study/NCT00900497","title":"A Phase I/II Study For the Use of White Blood Cells From Healthy Donor-participants To Treat Subjects With Solid Cancers","has_exemption":false,"start_date":"2009-04-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Dipnarine Maharaj","sponsor_slug":"dipnarine-maharaj","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00938145","publication_url":"https://clinicaltrials.gov/study/NCT00938145","title":"Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and EX-VIVO Ultra-High-Field MRI.","has_exemption":false,"start_date":"2009-07-08","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00978458","publication_url":"https://clinicaltrials.gov/study/NCT00978458","title":"Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas","has_exemption":false,"start_date":"2009-11-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Eastern Cooperative Oncology Group","sponsor_slug":"eastern-cooperative-oncology-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01025089","publication_url":"https://clinicaltrials.gov/study/NCT01025089","title":"A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (BMS #CA225-331/Lilly Trial Alias I4E-US-X007)","has_exemption":false,"start_date":"2009-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01241864","publication_url":"https://clinicaltrials.gov/study/NCT01241864","title":"Islet Transplantation in Type 1 Diabetic Kidney Allograft","has_exemption":false,"start_date":"2010-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01266096","publication_url":"https://clinicaltrials.gov/study/NCT01266096","title":"PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study","has_exemption":false,"start_date":"2011-01-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01310530","publication_url":"https://clinicaltrials.gov/study/NCT01310530","title":"Phase 2 Trial of Partial Breast Proton Therapy for Early Stage Breast Cancer With Low and Intermediate Risk Factors.","has_exemption":false,"start_date":"2011-05-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01386710","publication_url":"https://clinicaltrials.gov/study/NCT01386710","title":"Phase I/II Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory Glioblastoma Multiforme And Anaplastic Astrocytoma","has_exemption":false,"start_date":"2011-09-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01453127","publication_url":"https://clinicaltrials.gov/study/NCT01453127","title":"DaTSCAN Imaging in Aging and Neurodegenerative Disease","has_exemption":false,"start_date":"2011-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02011971","publication_url":"https://clinicaltrials.gov/study/NCT02011971","title":"Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy","has_exemption":false,"start_date":"2012-02-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01587352","publication_url":"https://clinicaltrials.gov/study/NCT01587352","title":"A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2012-05-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00692939","publication_url":"https://clinicaltrials.gov/study/NCT00692939","title":"Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Pediatric and Adult Patients With Severe Crohn's Disease","has_exemption":false,"start_date":"2012-06-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Paul Szabolcs","sponsor_slug":"paul-szabolcs","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00147056","publication_url":"https://clinicaltrials.gov/study/NCT00147056","title":"A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors","has_exemption":false,"start_date":"2012-08-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01746849","publication_url":"https://clinicaltrials.gov/study/NCT01746849","title":"Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2012-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01757626","publication_url":"https://clinicaltrials.gov/study/NCT01757626","title":"Phase I/II Study of Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma","has_exemption":false,"start_date":"2012-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01851694","publication_url":"https://clinicaltrials.gov/study/NCT01851694","title":"Determination of Beta-cell Responsiveness to the Incretin Hormones GLP-1 and GIP in Cystic Fibrosis","has_exemption":false,"start_date":"2013-05-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01918683","publication_url":"https://clinicaltrials.gov/study/NCT01918683","title":"A Pilot Trial of Transarterial Chemoembolization With or Without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation","has_exemption":false,"start_date":"2013-07-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02202590","publication_url":"https://clinicaltrials.gov/study/NCT02202590","title":"Pilot Study to Image the Esophagus Using Spectrally Encoded Confocal Microscopy (SECM)","has_exemption":false,"start_date":"2013-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01871766","publication_url":"https://clinicaltrials.gov/study/NCT01871766","title":"Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy","has_exemption":false,"start_date":"2013-12-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01863550","publication_url":"https://clinicaltrials.gov/study/NCT01863550","title":"Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)","has_exemption":false,"start_date":"2013-12-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02020070","publication_url":"https://clinicaltrials.gov/study/NCT02020070","title":"A Phase 2 Study Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy","has_exemption":false,"start_date":"2013-12-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02969798","publication_url":"https://clinicaltrials.gov/study/NCT02969798","title":"Preservation of Beta Cell Function in Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)","has_exemption":false,"start_date":"2014-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01712620","publication_url":"https://clinicaltrials.gov/study/NCT01712620","title":"A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension","has_exemption":false,"start_date":"2014-01-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institutes of Health Clinical Center (CC)","sponsor_slug":"national-institutes-of-health-clinical-center-cc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01896999","publication_url":"https://clinicaltrials.gov/study/NCT01896999","title":"A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma","has_exemption":false,"start_date":"2014-03-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02446405","publication_url":"https://clinicaltrials.gov/study/NCT02446405","title":"Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET","has_exemption":false,"start_date":"2014-03-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Sydney","sponsor_slug":"university-of-sydney","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02143830","publication_url":"https://clinicaltrials.gov/study/NCT02143830","title":"A Phase II Trial of HSCT for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Risk-Adjusted Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine","has_exemption":false,"start_date":"2014-04-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02087826","publication_url":"https://clinicaltrials.gov/study/NCT02087826","title":"Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS (SCRAMBLED EGGS)","has_exemption":false,"start_date":"2014-04-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00959140","publication_url":"https://clinicaltrials.gov/study/NCT00959140","title":"Phase II Study for Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplants From Matched Related Donors","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02068586","publication_url":"https://clinicaltrials.gov/study/NCT02068586","title":"A Randomized Phase ll Study of Adjuvant Sunitinib or Valproic Acid in High-Risk Patients With Uveal Melanoma","has_exemption":false,"start_date":"2014-11-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-thomas-jefferson-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02283996","publication_url":"https://clinicaltrials.gov/study/NCT02283996","title":"Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment","has_exemption":false,"start_date":"2014-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02286687","publication_url":"https://clinicaltrials.gov/study/NCT02286687","title":"Phase II Study of the PARP Inhibitor Talazoparib in Advanced Cancer Patients With Somatic Alterations in BRCA1/2, Mutations/Deletions in Other BRCA Pathway Genes and Germline Mutation in BRCA1/2 (Not Breast or Ovarian Cancer)","has_exemption":false,"start_date":"2014-12-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02312401","publication_url":"https://clinicaltrials.gov/study/NCT02312401","title":"Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy","has_exemption":false,"start_date":"2014-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02214836","publication_url":"https://clinicaltrials.gov/study/NCT02214836","title":"Ultrasound Imaging of Kidney Stones and Lithotripsy","has_exemption":false,"start_date":"2015-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02340117","publication_url":"https://clinicaltrials.gov/study/NCT02340117","title":"Phase II Study of Combined Targeted p53 Gene Therapy (SGT-53) Plus Gemcitabine/Nab-Paclitaxel for Treatment of Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2015-01-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"SynerGene Therapeutics, Inc.","sponsor_slug":"synergene-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02912949","publication_url":"https://clinicaltrials.gov/study/NCT02912949","title":"A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors (eNRGy)","has_exemption":false,"start_date":"2015-01-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Partner Therapeutics, Inc.","sponsor_slug":"partner-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02320435","publication_url":"https://clinicaltrials.gov/study/NCT02320435","title":"A Single-Arm Open-Label Multi-Centre Extension Study of Pertuzumab Administered As a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Study","has_exemption":false,"start_date":"2015-02-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02381353","publication_url":"https://clinicaltrials.gov/study/NCT02381353","title":"Postoperative Pain Control After Enucleation or Evisceration, a Double-Masked Randomized Controlled Trial of Standard Versus Slow-release Bupivacaine","has_exemption":false,"start_date":"2015-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02387905","publication_url":"https://clinicaltrials.gov/study/NCT02387905","title":"Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery: A Randomized Phase II Clinical Trial","has_exemption":false,"start_date":"2015-03-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02503475","publication_url":"https://clinicaltrials.gov/study/NCT02503475","title":"Stanford Center for Back Pain","has_exemption":false,"start_date":"2015-03-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05708898","publication_url":"https://clinicaltrials.gov/study/NCT05708898","title":"Effect of Pharyngeal Exerciser in Rehabilitation of Pharyngeal Phase of Swallowing in Patients With Dysphagia","has_exemption":false,"start_date":"2015-06-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02465060","publication_url":"https://clinicaltrials.gov/study/NCT02465060","title":"Molecular Analysis for Therapy Choice (MATCH)","has_exemption":false,"start_date":"2015-08-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02532452","publication_url":"https://clinicaltrials.gov/study/NCT02532452","title":"Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients","has_exemption":false,"start_date":"2015-09-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03127631","publication_url":"https://clinicaltrials.gov/study/NCT03127631","title":"The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)","has_exemption":false,"start_date":"2015-10-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"McMaster University","sponsor_slug":"mcmaster-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02600208","publication_url":"https://clinicaltrials.gov/study/NCT02600208","title":"BT13BTθ51 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation with Alpha Beta T Cell and B Cell Depletion for Patients with Hematologic Malignancies","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Julie-An M. Talano","sponsor_slug":"julie-an-m-talano","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03307382","publication_url":"https://clinicaltrials.gov/study/NCT03307382","title":"Evaluation of the Utility of Single-operator Digital Cholangioscopy During Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Malignant and Benign Biliary Strictures","has_exemption":false,"start_date":"2015-12-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06357988","publication_url":"https://clinicaltrials.gov/study/NCT06357988","title":"MATCH Treatment Subprotocol T: GDC-0449 (Vismodegib) in Patients With Tumors (Except Basal Cell Skin Carcinoma) With Smoothened (SMO) or Patched 1 (PTCH1) Mutations","has_exemption":false,"start_date":"2016-02-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02718833","publication_url":"https://clinicaltrials.gov/study/NCT02718833","title":"A Phase II Study of Elotuzumab in Combination With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma","has_exemption":false,"start_date":"2016-06-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02861898","publication_url":"https://clinicaltrials.gov/study/NCT02861898","title":"Phase I/II Trial of Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2016-06-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02744677","publication_url":"https://clinicaltrials.gov/study/NCT02744677","title":"COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV","has_exemption":false,"start_date":"2016-07-05","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02595944","publication_url":"https://clinicaltrials.gov/study/NCT02595944","title":"Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers","has_exemption":false,"start_date":"2016-07-22","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02584244","publication_url":"https://clinicaltrials.gov/study/NCT02584244","title":"Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers","has_exemption":false,"start_date":"2016-08-04","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Lumicell, Inc.","sponsor_slug":"lumicell-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02754752","publication_url":"https://clinicaltrials.gov/study/NCT02754752","title":"Randomized-Controlled Trial of Acupuncture for Chronic Pain After Breast Cancer Treatment","has_exemption":false,"start_date":"2016-09-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02886585","publication_url":"https://clinicaltrials.gov/study/NCT02886585","title":"Phase II Trial of Pembrolizumab in Central Nervous System Metastases From Multiple Histologies","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02935361","publication_url":"https://clinicaltrials.gov/study/NCT02935361","title":"A Phase I/II Multicenter Study Combining Guadecitabine, a DNA Methyltransferase Inhibitor, With Atezolizumab, an Immune Checkpoint Inhibitor, in Patients With Intermediate or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia","has_exemption":false,"start_date":"2016-11-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02989584","publication_url":"https://clinicaltrials.gov/study/NCT02989584","title":"A Pilot Safety Study and Single Arm Phase II Study of Gemcitabine and Cisplatin With Atezolizumab (MPDL3280A) in Patients With Metastatic and Muscle Invasive Bladder Cancer, Respectively","has_exemption":false,"start_date":"2016-12-20","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03028246","publication_url":"https://clinicaltrials.gov/study/NCT03028246","title":"A Feasibility Safety Study Using the ExAblate 4000 System in the Management of Benign Centrally-Located Intracranial Tumors Which Require Clinical Intervention in Pediatric and Young Adult Subjects","has_exemption":false,"start_date":"2017-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04204837","publication_url":"https://clinicaltrials.gov/study/NCT04204837","title":"Phase II Study of Nivolumab (Group 1) and Nivolumab Plus Relatlimab (Group 2) in Patients With Locally Advanced/ Metastatic Squamous Cell Carcinoma of the Skin","has_exemption":false,"start_date":"2017-03-06","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Salzburger Landeskliniken","sponsor_slug":"salzburger-landeskliniken","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03093961","publication_url":"https://clinicaltrials.gov/study/NCT03093961","title":"A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients With Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2017-03-10","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Corvia Medical","sponsor_slug":"corvia-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06385496","publication_url":"https://clinicaltrials.gov/study/NCT06385496","title":"MATCH Treatment Subprotocol L: Phase II Study of MLN0128 (TAK-228) in Patients With Tumors Wtih mTOR Mutations","has_exemption":false,"start_date":"2017-03-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06390852","publication_url":"https://clinicaltrials.gov/study/NCT06390852","title":"MATCH Treatment Subprotocol Z1E: Larotrectinib (LOXO-101) in Patients With Tumors With NTRK Fusions","has_exemption":false,"start_date":"2017-03-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06390865","publication_url":"https://clinicaltrials.gov/study/NCT06390865","title":"MATCH Treatment Subprotocol M: Phase II Study of MLN0128 (Tak-228) in Patients With Tumors With TSC1 or TSC2 Mutations","has_exemption":false,"start_date":"2017-03-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02344355","publication_url":"https://clinicaltrials.gov/study/NCT02344355","title":"Pharmacological Ascorbate Combined With Radiation and Temozolomide in Glioblastoma Multiforme: A Phase 2 Trial","has_exemption":false,"start_date":"2017-03-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Bryan Allen","sponsor_slug":"bryan-allen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04439227","publication_url":"https://clinicaltrials.gov/study/NCT04439227","title":"MATCH Treatment Subprotocol Z1I: Phase II Study of AZD1775 in Patients With Tumors Containing BRCA1 and BRCA2 Mutations","has_exemption":false,"start_date":"2017-03-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03096093","publication_url":"https://clinicaltrials.gov/study/NCT03096093","title":"A Phase I Clinical Study to Determine the Optimal Dose for the Safe Immune Restoration and Immune Response of Allogeneic Cell Immunotherapy (ACIT-1) in Adult Cancer Patients","has_exemption":false,"start_date":"2017-04-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Cancer Vaccines Limited","sponsor_slug":"cancer-vaccines-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03099356","publication_url":"https://clinicaltrials.gov/study/NCT03099356","title":"An Open Label Phase II Trial Evaluating the Efficacy of Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer","has_exemption":false,"start_date":"2017-04-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03639701","publication_url":"https://clinicaltrials.gov/study/NCT03639701","title":"Deoxythymidine and Deoxycytidine Treatment for Thymidine Kinase 2 (TK2) Deficiency","has_exemption":false,"start_date":"2017-05-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02981628","publication_url":"https://clinicaltrials.gov/study/NCT02981628","title":"A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)","has_exemption":false,"start_date":"2017-06-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03165734","publication_url":"https://clinicaltrials.gov/study/NCT03165734","title":"A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Count <50,000/μL)(PACIFICA)","has_exemption":false,"start_date":"2017-06-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02675959","publication_url":"https://clinicaltrials.gov/study/NCT02675959","title":"Safety and Efficacy of Prophylactic Defibrotide in Children, Adolescents, and Young Adults With Sickle Cell Disease or Beta Thalassemia Following MAC and Haploidentical Stem Cell Transplantation Utilizing CD34 Enrichment and T-Cell (CD3) Addback","has_exemption":false,"start_date":"2017-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03223922","publication_url":"https://clinicaltrials.gov/study/NCT03223922","title":"Preservation of Cognition and Neuropsychiatric Functioning With Corpus Callosum Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases: A Pilot Study","has_exemption":false,"start_date":"2017-07-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02935478","publication_url":"https://clinicaltrials.gov/study/NCT02935478","title":"A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization in Obese Patients With Hepatocellular Carcinoma to Achieve Appropriate Weight Loss That May Allow Them to be Transplanted","has_exemption":false,"start_date":"2017-10-18","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03286530","publication_url":"https://clinicaltrials.gov/study/NCT03286530","title":"Phase II Study of Maintenance Ruxolitinib After Allogeneic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) in Complete Remission","has_exemption":false,"start_date":"2017-11-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03339128","publication_url":"https://clinicaltrials.gov/study/NCT03339128","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Participants (Age 6 to 17 Years) With Irritable Bowel Syndrome With Diarrhea (IBS-D)","has_exemption":false,"start_date":"2017-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03317158","publication_url":"https://clinicaltrials.gov/study/NCT03317158","title":"PhAse 1/2 StuDy of Modern ImmunotherApy in BCG-Unresponsive, BCG-RelaPsing, and High-Risk BCG-Naive Non-muscle Invasive UroThelial Carcinoma of the BLADDER","has_exemption":false,"start_date":"2017-11-21","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Noah Hahn, M.D.","sponsor_slug":"noah-hahn-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02901184","publication_url":"https://clinicaltrials.gov/study/NCT02901184","title":"Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF","has_exemption":false,"start_date":"2017-11-23","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Uppsala University","sponsor_slug":"uppsala-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03377387","publication_url":"https://clinicaltrials.gov/study/NCT03377387","title":"Phase Ib/II Study of Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer","has_exemption":false,"start_date":"2017-12-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03142152","publication_url":"https://clinicaltrials.gov/study/NCT03142152","title":"Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With Functional Mitral Regurgitation","has_exemption":false,"start_date":"2018-01-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Cardiac Dimensions, Inc.","sponsor_slug":"cardiac-dimensions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03224000","publication_url":"https://clinicaltrials.gov/study/NCT03224000","title":"Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer","has_exemption":false,"start_date":"2018-01-17","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03982160","publication_url":"https://clinicaltrials.gov/study/NCT03982160","title":"Role of Decreased Nitric Oxide in the Tonic Elevation of Resting Sympathetic Nerve Activity in Chronic Kidney Disease Patients","has_exemption":false,"start_date":"2018-02-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03161522","publication_url":"https://clinicaltrials.gov/study/NCT03161522","title":"A Randomized Trial Comparing Early Local Chemoradiation Therapy +/- Surgery Versus Systemic Therapy for Patients With Esophageal or Gastric Cancer With Oligometastases","has_exemption":false,"start_date":"2018-02-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03603405","publication_url":"https://clinicaltrials.gov/study/NCT03603405","title":"Phase I-II Study Evaluating HSV-tK + VALACYCLOVIR GENE THERAPY Combination With Radiotherapy and Chemotherapy for Newly Diagnosed Anaplastic Astrocytoma and Glioblastoma Multiforme.","has_exemption":false,"start_date":"2018-02-28","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03431090","publication_url":"https://clinicaltrials.gov/study/NCT03431090","title":"HAPLEUK17, Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia","has_exemption":false,"start_date":"2018-03-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03383094","publication_url":"https://clinicaltrials.gov/study/NCT03383094","title":"Phase II Randomized Trial of Radiotherapy With Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients With Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN)","has_exemption":false,"start_date":"2018-03-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Loren Mell, MD","sponsor_slug":"loren-mell-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03420482","publication_url":"https://clinicaltrials.gov/study/NCT03420482","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","has_exemption":false,"start_date":"2018-04-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03519451","publication_url":"https://clinicaltrials.gov/study/NCT03519451","title":"Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment - A Pilot Study","has_exemption":false,"start_date":"2018-04-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03467867","publication_url":"https://clinicaltrials.gov/study/NCT03467867","title":"A Phase II Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL","has_exemption":false,"start_date":"2018-04-26","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03441113","publication_url":"https://clinicaltrials.gov/study/NCT03441113","title":"Extended Access of Momelotinib for Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)","has_exemption":false,"start_date":"2018-05-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03604198","publication_url":"https://clinicaltrials.gov/study/NCT03604198","title":"An Open-Label Extension Study of the Safety of Relacorilant (CORT125134) in the Treatment of the Signs and Symptoms of Endogenous Cushing Syndrome","has_exemption":false,"start_date":"2018-05-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03473249","publication_url":"https://clinicaltrials.gov/study/NCT03473249","title":"Clinical Effectiveness of Contrast-Enhanced Ultrasound in the Evaluation of Blunt Abdominal Trauma in Young Children","has_exemption":false,"start_date":"2018-05-09","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03533582","publication_url":"https://clinicaltrials.gov/study/NCT03533582","title":"Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)","has_exemption":false,"start_date":"2018-05-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03491683","publication_url":"https://clinicaltrials.gov/study/NCT03491683","title":"An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)","has_exemption":false,"start_date":"2018-05-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Inovio Pharmaceuticals","sponsor_slug":"inovio-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03490929","publication_url":"https://clinicaltrials.gov/study/NCT03490929","title":"Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children","has_exemption":false,"start_date":"2018-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03230565","publication_url":"https://clinicaltrials.gov/study/NCT03230565","title":"A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion","has_exemption":false,"start_date":"2018-06-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03626038","publication_url":"https://clinicaltrials.gov/study/NCT03626038","title":"A.L.P.S. Proximal Humerus Plating System Post-Market Clinical Follow-up Study","has_exemption":false,"start_date":"2018-06-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03382457","publication_url":"https://clinicaltrials.gov/study/NCT03382457","title":"Clinical Study of Edwards Cardioband FIT Valve Repair System","has_exemption":false,"start_date":"2018-07-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03301038","publication_url":"https://clinicaltrials.gov/study/NCT03301038","title":"Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Inactivating Mutations in the CYP24A1 Gene","has_exemption":false,"start_date":"2018-07-25","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03525873","publication_url":"https://clinicaltrials.gov/study/NCT03525873","title":"A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy","has_exemption":false,"start_date":"2018-08-02","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03487185","publication_url":"https://clinicaltrials.gov/study/NCT03487185","title":"A Randomized Trial of Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy","has_exemption":false,"start_date":"2018-08-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The George Washington University Biostatistics Center","sponsor_slug":"the-george-washington-university-biostatistics-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03603912","publication_url":"https://clinicaltrials.gov/study/NCT03603912","title":"Upstream Targeting for the Prevention of Atrial Fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)","has_exemption":false,"start_date":"2018-08-24","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mina Chung, MD","sponsor_slug":"mina-chung-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03394066","publication_url":"https://clinicaltrials.gov/study/NCT03394066","title":"Understanding the Acute Modulation of Brain Activity by Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2018-09-19","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Institute on Drug Abuse (NIDA)","sponsor_slug":"national-institute-on-drug-abuse-nida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03412760","publication_url":"https://clinicaltrials.gov/study/NCT03412760","title":"Hydrops: Diagnosing & Redefining Outcomes With Precision Study","has_exemption":false,"start_date":"2018-10-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03629171","publication_url":"https://clinicaltrials.gov/study/NCT03629171","title":"Phase II Study of CPX-351 in Combination With Venetoclax in Patients With Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2018-10-29","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266627","publication_url":"https://clinicaltrials.gov/study/NCT03266627","title":"A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infection With Related Donor ADV Cytotoxic T-Lymphocytes (ADV-CTLs)in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2018-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03266640","publication_url":"https://clinicaltrials.gov/study/NCT03266640","title":"A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections With Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients","has_exemption":false,"start_date":"2018-11-01","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254794","publication_url":"https://clinicaltrials.gov/study/NCT06254794","title":"Effect of Blood Flow Restriction (BFR) Rehabilitation After Achilles Tendon Rupture Reconstruction","has_exemption":false,"start_date":"2018-11-13","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03712605","publication_url":"https://clinicaltrials.gov/study/NCT03712605","title":"STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial","has_exemption":false,"start_date":"2018-11-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03747146","publication_url":"https://clinicaltrials.gov/study/NCT03747146","title":"Expanding the Peri-operative Surgical Home Model: ERAS TKR With a Transitional Pain Service (TeleTPS)- Continuous Adductor Canal Catheter Versus Adductor Canal Block for Total Knee Arthroplasty, a Randomized Double-blind Controlled Trial","has_exemption":false,"start_date":"2018-11-16","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03637816","publication_url":"https://clinicaltrials.gov/study/NCT03637816","title":"Qualitative Study on Experiences Related to Anorexia and the Effects of Anamorelin and Placebo in Advanced Non-Small-Cell Lung Cancer Patients With Anorexia-Cachexia: A Preliminary Study","has_exemption":false,"start_date":"2018-11-27","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737955","publication_url":"https://clinicaltrials.gov/study/NCT03737955","title":"A Phase 2 Trial of Fractionated Gemtuzumab Ozogamicin to Eradicate Measurable Residual Disease in Acute Myeloid Leukemia Patients (GO for MRD)","has_exemption":true,"start_date":"2018-11-30","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03579316","publication_url":"https://clinicaltrials.gov/study/NCT03579316","title":"EFFORT: Efficacy of AZD1775 in Parp Resistance; A Randomized 2-Arm, Non-Comparative Phase 2 Study of AZD1775 Alone or AZD1775 and Olaparib in Women With Ovarian Cancer Who Have Progressed During PARP Inhibition","has_exemption":false,"start_date":"2018-12-07","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03349528","publication_url":"https://clinicaltrials.gov/study/NCT03349528","title":"A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression","has_exemption":false,"start_date":"2018-12-11","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Sheppard Pratt Health System","sponsor_slug":"sheppard-pratt-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03694756","publication_url":"https://clinicaltrials.gov/study/NCT03694756","title":"TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer","has_exemption":false,"start_date":"2018-12-12","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793140","publication_url":"https://clinicaltrials.gov/study/NCT03793140","title":"A Phase II Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-grade B-cell Lymphoma With Rearrangements of MYC and BCL2 and/or BCL6","has_exemption":false,"start_date":"2018-12-31","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587701","publication_url":"https://clinicaltrials.gov/study/NCT03587701","title":"A Phase II Placebo Controlled Study of the Effects of Anakinra (Kineret) in Subjects With Corticosteroid-Resistant/Intolerant Meniere's Disease (CR-MD) and Corticosteroid-Resistant/Intolerant Autoimmune Inner Ear Disease Disease (CR-AIED)","has_exemption":false,"start_date":"2019-01-03","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03785249","publication_url":"https://clinicaltrials.gov/study/NCT03785249","title":"A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-12-31","has_results":false,"results_due":false,"sponsor_name":"Mirati Therapeutics Inc.","sponsor_slug":"mirati-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null}]}